Toxic anterior segment syndrome – causes and recomendations for prevention
Abstract
Toxic Anterior Segment Syndrome – TASS is an acute, sterile inflammation of the anterior segment. With appropriate treatment it may either resolve without consequences or it may result in secondary glaucoma or corneal decomposition requiring a corneal graft. TASS is becoming more of a problem lately due to better recognition as well as due to an increased incidence of the syndrome. The occurrence of TASS cannot be eliminated completely, but we can decrease its frequency if we stick firmly to certain regulations. Adoption and implementation of best practices for cleaning and sterilization of surgical instruments, and a traceability system for surgical instruments as well as for all intraocular fluids used during the surgery, can decrease the occurrence of TASS and improve the probability of finding its cause.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
